News
-
-
PRESS RELEASE
Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found
NanoViricides, Inc. successfully completes Phase 1a/1b Clinical Trial of NV-CoV-2, reporting excellent safety and broad-spectrum antiviral activity of NV-387 against various respiratory viruses including Coronaviruses and RSV -
-
PRESS RELEASE
EQS-Adhoc: Bilfinger SE: EBITA margin and free cash flow in financial year 2023 exceeded outlook
Bilfinger SE reports EBITA margin for 2023 financial year exceeded outlook at 4.3% and free cash flow expected to be € 122 million, surpassing outlook by € 42 million. Revenue to be within outlook range. Mid-term targets confirmed -
PRESS RELEASE
EQS-Adhoc: Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
Carl Zeiss Meditec AG has approved a share buyback program of up to €150m, representing 1.7% of share capital, starting on 9 February 2024. The company may discontinue the program at any time -
PRESS RELEASE
New evidence informs risk factors, diagnosis and care of patients with CVT stroke
American Heart Association releases a new scientific statement emphasizing the need to increase awareness of cerebral venous thrombosis (CVT) to improve recognition and initiate prompt medical treatment. The statement reviews the latest evidence and updates recommendations for diagnosing and managing CVT, focusing on advancements in treatment approaches -
PRESS RELEASE
Original-Research: Avemio AG (von GBC AG): Kaufen
Avemio AG veröffentlicht vorläufige Zahlen für das abgelaufene Geschäftsjahr 2023 und bestätigt das Kauf-Rating trotz Umsatz- und Ergebnisrückgang. Neue Prognose und Kursziel von 32,00 EUR für 2024. Solide Kapitalausstattung und M&A-Wachstum geplant -
-
PRESS RELEASE
Answering Legal Announces Release of New App
Answering Legal, a 24/7 phone answering service for attorneys, launches new app to help lawyers manage incoming calls, messages, and new client intakes from their mobile devices. The app aims to provide organization, clarity, and full control of lead-capturing efforts for law offices -
PRESS RELEASE
Mary Rose McCaffrey to Join SIMS Software’s Board of Advisors
SIMS Software announces addition of Mary Rose McCaffrey to its board of advisors, bringing wealth of experience and expertise in security and national defense. Ms. McCaffrey will provide strategic guidance to executive management and help increase awareness of company's product capabilities to national security community
